Annual EBIT
-$96.78 M
+$30.16 M+23.76%
December 1, 2024
Summary
- As of March 10, 2025, ATHA annual earnings before interest & taxes is -$96.78 million, with the most recent change of +$30.16 million (+23.76%) on December 1, 2024.
- During the last 3 years, ATHA annual EBIT has fallen by -$41.59 million (-75.36%).
- ATHA annual EBIT is now -1909.87% below its all-time high of -$4.82 million, reached on December 31, 2019.
Performance
ATHA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$15.57 M
+$9.93 M+38.94%
December 1, 2024
Summary
- As of March 10, 2025, ATHA quarterly earnings before interest & taxes is -$15.57 million, with the most recent change of +$9.93 million (+38.94%) on December 1, 2024.
- Over the past year, ATHA quarterly EBIT has stayed the same.
- ATHA quarterly EBIT is now -1701.62% below its all-time high of -$864.00 thousand, reached on December 31, 2019.
Performance
ATHA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$96.78 M
+$15.08 M+13.48%
December 1, 2024
Summary
- As of March 10, 2025, ATHA TTM earnings before interest & taxes is -$96.78 million, with the most recent change of +$15.08 million (+13.48%) on December 1, 2024.
- Over the past year, ATHA TTM EBIT has stayed the same.
- ATHA TTM EBIT is now -6658.03% below its all-time high of -$1.43 million, reached on September 30, 2019.
Performance
ATHA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ATHA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.8% | 0.0% | 0.0% |
| 3 y3 years | -75.4% | 0.0% | 0.0% |
| 5 y5 years | -1909.9% | 0.0% | 0.0% |
ATHA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -75.4% | +23.8% | at high | +55.6% | -75.6% | +23.8% |
| 5 y | 5-year | -1909.9% | +23.8% | -1701.6% | +55.6% | -4114.9% | +23.8% |
| alltime | all time | -1909.9% | +23.8% | -1701.6% | +55.6% | -6658.0% | +23.8% |
Athira Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$96.78 M(-23.8%) | -$15.57 M(-38.9%) | -$96.78 M(-13.5%) |
| Sep 2024 | - | -$25.49 M(-9.0%) | -$111.85 M(-7.9%) |
| Jun 2024 | - | -$28.03 M(+1.2%) | -$121.40 M(-2.9%) |
| Mar 2024 | - | -$27.69 M(-9.6%) | -$125.01 M(-1.5%) |
| Dec 2023 | -$126.94 M(+42.9%) | -$30.64 M(-12.6%) | -$126.94 M(+7.6%) |
| Sep 2023 | - | -$35.04 M(+10.8%) | -$118.00 M(+13.3%) |
| Jun 2023 | - | -$31.64 M(+6.8%) | -$104.13 M(+7.0%) |
| Mar 2023 | - | -$29.61 M(+36.5%) | -$97.31 M(+9.5%) |
| Dec 2022 | -$88.86 M | -$21.70 M(+2.5%) | -$88.86 M(+6.3%) |
| Sep 2022 | - | -$21.17 M(-14.7%) | -$83.60 M(+6.9%) |
| Jun 2022 | - | -$24.83 M(+17.4%) | -$78.17 M(+16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$21.15 M(+28.7%) | -$67.39 M(+22.3%) |
| Dec 2021 | -$55.19 M(+181.7%) | -$16.44 M(+4.4%) | -$55.10 M(+18.9%) |
| Sep 2021 | - | -$15.75 M(+12.1%) | -$46.36 M(+18.7%) |
| Jun 2021 | - | -$14.05 M(+58.4%) | -$39.07 M(+45.4%) |
| Mar 2021 | - | -$8.87 M(+15.1%) | -$26.87 M(+37.2%) |
| Dec 2020 | -$19.59 M(+306.8%) | -$7.70 M(-8.9%) | -$19.59 M(+53.6%) |
| Sep 2020 | - | -$8.46 M(+358.6%) | -$12.75 M(+122.6%) |
| Jun 2020 | - | -$1.84 M(+16.2%) | -$5.73 M(+47.5%) |
| Mar 2020 | - | -$1.59 M(+83.7%) | -$3.88 M(+69.1%) |
| Dec 2019 | -$4.82 M(-5.4%) | -$864.00 K(-39.7%) | -$2.30 M(+60.3%) |
| Sep 2019 | - | -$1.43 M | -$1.43 M |
| Dec 2018 | -$5.09 M | - | - |
FAQ
- What is Athira Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Athira Pharma?
- What is Athira Pharma annual EBIT year-on-year change?
- What is Athira Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Athira Pharma?
- What is Athira Pharma quarterly EBIT year-on-year change?
- What is Athira Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Athira Pharma?
- What is Athira Pharma TTM EBIT year-on-year change?
What is Athira Pharma annual earnings before interest & taxes?
The current annual EBIT of ATHA is -$96.78 M
What is the all time high annual EBIT for Athira Pharma?
Athira Pharma all-time high annual earnings before interest & taxes is -$4.82 M
What is Athira Pharma annual EBIT year-on-year change?
Over the past year, ATHA annual earnings before interest & taxes has changed by +$30.16 M (+23.76%)
What is Athira Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of ATHA is -$15.57 M
What is the all time high quarterly EBIT for Athira Pharma?
Athira Pharma all-time high quarterly earnings before interest & taxes is -$864.00 K
What is Athira Pharma quarterly EBIT year-on-year change?
Over the past year, ATHA quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Athira Pharma TTM earnings before interest & taxes?
The current TTM EBIT of ATHA is -$96.78 M
What is the all time high TTM EBIT for Athira Pharma?
Athira Pharma all-time high TTM earnings before interest & taxes is -$1.43 M
What is Athira Pharma TTM EBIT year-on-year change?
Over the past year, ATHA TTM earnings before interest & taxes has changed by $0.00 (0.00%)